587 related articles for article (PubMed ID: 15757475)
1. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
Davison F; Nair V
Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
[TBL] [Abstract][Full Text] [Related]
2. Successful control of Marek's disease by vaccination.
Nair V
Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
4. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
Baigent SJ; Smith LP; Nair VK; Currie RJ
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ
Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339
[TBL] [Abstract][Full Text] [Related]
6. Marek's disease: a model for protection against herpesvirus-induced tumours.
Schat KA
Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Marek's disease: a review.
Purchase HG
Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
[TBL] [Abstract][Full Text] [Related]
10. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses.
Gimeno IM; Cortes AL; Montiel ER; Lemiere S; Pandiri AK
Avian Dis; 2011 Jun; 55(2):263-72. PubMed ID: 21793444
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.
Nair V
Vet J; 2005 Sep; 170(2):175-83. PubMed ID: 16129338
[TBL] [Abstract][Full Text] [Related]
12. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge.
Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
Aust Vet J; 2007 Sep; 85(9):348-55. PubMed ID: 17760936
[TBL] [Abstract][Full Text] [Related]
13. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
Tarpey I; Davis PJ; Sondermeijer P; van Geffen C; Verstegen I; Schijns VE; Kolodsick J; Sundick R
Avian Pathol; 2007 Feb; 36(1):69-74. PubMed ID: 17364512
[TBL] [Abstract][Full Text] [Related]
14. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
Buscaglia C; Nervi P; Risso M
Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
[TBL] [Abstract][Full Text] [Related]
15. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
[TBL] [Abstract][Full Text] [Related]
16. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time.
Fakhrul Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
Avian Pathol; 2008 Jun; 37(3):225-35. PubMed ID: 18568648
[TBL] [Abstract][Full Text] [Related]
18. Marek's disease virus: lytic replication, oncogenesis and control.
Jarosinski KW; Tischer BK; Trapp S; Osterrieder N
Expert Rev Vaccines; 2006 Dec; 5(6):761-72. PubMed ID: 17184215
[TBL] [Abstract][Full Text] [Related]
19. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
Baaten BJ; Butter C; Davison TF
Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
[TBL] [Abstract][Full Text] [Related]
20. Marek's disease virus: from miasma to model.
Osterrieder N; Kamil JP; Schumacher D; Tischer BK; Trapp S
Nat Rev Microbiol; 2006 Apr; 4(4):283-94. PubMed ID: 16541136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
